Hormone Replacement Therapy & Bone Health: Cyplexinol Nutritional Support
On average bone density decreases by 10% in women during the five years of menopause due to changes in estrogen. While Hormone Replacement Therapy offers support in maintaining bone health, there can be a precipitous loss when women discontinue HRT.
Along with the decline in estrogen, there is a concurrent 40% drop in production of bone-stimulating Growth Factor Proteins in the menopausal period, which can lead to dysregulation of bone remodeling.
While HRT is well-established for estrogen support, there’s a largely unmet need to address this decline of Growth Factor Proteins.
In this free webinar, women’s health expert Jaquel Patterson, ND, will explore how a nutraceutical called Cyplexinol®–a growth factor complex patented for osteoinductive properties–can be used support HRT protocols for improved bone density outcomes.
Discover how the age-related decreases in estrogen and Growth Factor Proteins affect women’s bone health, and the nutritional interventions you can provide to support healthy bone remodeling.
SPONSORED BY ZYCAL BIOCEUTICALS
Jaquel Patterson, ND, MBA is the founder and medical director of Fairfield Family Health, an integrative medicine clinic in Fairfield, CT. Dr. Patterson is a nationally-recognized naturopathic physician, specializing in Lyme disease, autoimmune conditions, anxiety/depression, childhood developmental disorders, and women’s health. She received her ND degree from the University of Bridgeport College of Naturopathic Medicine, and earned an MBA in healthcare administration from Quinnipiac University. She is a past-president of the American Association of Naturopathic Physicians, and a popular author and speaker for many health and fitness media outlets.